The market for radioligand therapies (RLT), also known as radiopharmaceuticals, a relatively new kind of treatment, is ...

Ho Chi Minh City is currently facing a critical shortage of radiopharmaceuticals needed for PET/CT scans, crucial in ...

Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer ...

Just two years into its existence, radioisotope producer PanTera has drawn 93 million euros ($102.5 million) in an ...

The market for radiopharmaceuticals has the potential to grow to "tens of billions" if the drugs prove to be effective, according to a Sept. 16 report from CNBC .

The global radiopharmaceuticals market size is calculated at USD 6.74 billion in 2024 and is expected to achieve around USD 13.67 billion by 2033, representing a healthy CAGR of 8.2% from 2024 to 2033 ...

This report is a review of recent and emerging trends that promise to make radiation oncology for prostate cancer more ...

The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

IAEA scientific and technical publications can be searched by multiple parameters: year of publication, topic and type. Use the facets to input your search criteria or the text field to search by ...

Two new papers by a team of researchers at Boston University, the Indiana University School of Medicine and the Alzheimer’s Disease Neuroimaging Initiative (ADNI), and the German Center for ...

Unearthing novel targets for radiopharmaceuticals from ACP3m, AVB6, AVB8, and PDL-1 with Philochem, TRIMT, Fusion-AstraZeneca ...